#MakeHistory: Highlighting History I China

Venture capital investment in US biotech companies has skyrocketed as Chinese investors continue to fuel the US pharmaceutical startup sector. With over $1.4 billion invested by Chinese VC funds into private US biotechnology firms in Q1 2018 alone, the Chinese investment community represents a materially significant and growing source of growth capital for the industry.
While recent trade rifts between the US and China have threatened industries including US coal producers, farmers and crude oil